Latest Research Hot Spots of Atopic Dermatitis Management Using Janus Kinase Inhibitor: A Bibliometric Analysis and Visualized Review

Houriah Nukaly, Deemah S AlHuraish, Basel H Bakhamees, Haya A AlHemli, Mai S Alsaadoon, Renad K Alhejji, Ghaid Alotaibi, Shikhah A Alomran, Zeinah AlHalees · 2025

Read Latest Research Hot Spots of Atopic Dermatitis Management Using Janus Kinase Inhibitor: A Bibliometric Analysis and Visualized Review by Houriah Nukaly, Deemah S AlHuraish, Basel H Bakhamees, Haya A AlHemli, Mai S Alsaadoon, Renad K Alhejji, Ghaid Alotaibi, Shikhah A Alomran, Zeinah AlHalees (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12710625.txt.

Description

Houriah Nukaly and eight co-authors published a bibliometric review in 2025 mapping research on a drug class for severe eczema. Janus kinase inhibitors changed the options for moderate to severe disease, and papers multiplied fast. Rather than testing a treatment, the team charted the field itself: who publishes, where, and on what hot topics.

They gathered 776 papers from a major citation database covering twenty fourteen to twenty twenty-four. The United States led output, followed by Germany, Japan, and China. Two American centers published most, while a Japanese university drew the most citations per paper. Two senior researchers topped the author list. The maps show newcomers where the active fronts and the strong partnerships sit.

Catalog record

CREATORHouriah Nukaly, Deemah S AlHuraish, Basel H Bakhamees, Haya A AlHemli, Mai S Alsaadoon, Renad K Alhejji, Ghaid Alotaibi, Shikhah A Alomran, Zeinah AlHalees
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12710625

Browse the full library · About the Tower of Babel